Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Piloting a Novel, Mobile Cognitive Tracking and Training Tool for Patients With Parkinson's Disease (PD)

Trial N/A Withdrawn Feb. 22, 2017

Transcutaneous Electric Nerve Stimulation in Sleep of Patients With Parkinson's Disease

Trial N/A Completed Feb. 14, 2017

Virtual Reality in Parkinson Disease

Trial N/A Completed Feb. 13, 2017

Expiratory Muscle Training for Persons With Neurodegenerative Disease

Trial Phase 2 Completed Feb. 9, 2017

A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders

Trial Phase 2 Completed Feb. 8, 2017

Evolution of RBD in PD

Trial N/A Unknown Feb. 8, 2017

Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)

Trial Phase 2 Withdrawn Feb. 6, 2017

Erythromycin in Parkinson's Disease

Trial N/A Completed Feb. 2, 2017

Computerized Cognitive Behavioral Therapy Trial for Insomnia in Parkinson Disease

Trial N/A Completed Feb. 1, 2017

Subthalamotomy by ExAblate Transcranial System to Treat Motor Features of Parkinson's Disease

Trial N/A Completed Jan. 30, 2017

A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)

Trial Phase 1 Completed Jan. 29, 2017

Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease

Trial Phase 4 Completed Jan. 29, 2017

Connect.Parkinson: Connecting Individuals With Parkinson Disease to Specialists in Their Homes

Trial N/A Completed Jan. 26, 2017

Behavioural Addiction and Genetics in Parkinson's Disease

Trial N/A Completed Jan. 24, 2017

Freezing of Gait in Parkinson's Disease

Trial N/A Completed Jan. 23, 2017

Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease

Trial Phase 4 Terminated Jan. 23, 2017

Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia

Trial Phase 2 Completed Jan. 22, 2017

Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease

Trial Phase 3 Completed Jan. 17, 2017

Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

Trial Phase 3 Completed Jan. 17, 2017

Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation

Trial N/A Completed Jan. 11, 2017